About
Please note that the webinar room will open at 3:55 PM CET Time.

Review and discuss research regarding non-hepatic malignancy in the candidate, the donor or the recipient, including selection criteria/indications, prognostic models, surveillance strategies, novel therapies and management.
Gain insight into innovations that lead to improvement in the field of liver transplantation in candidates or donors with a history of malignancy, and in recipients with de novo cancer, both in adult and pediatric populations.
Agenda
  • Incidence and risk factors - Kymberly Watt, MD
  • Screening strategies after liver transplantation - José Ignacio Herrero, MD
  • Treatment for solid tumors - Gonzalo Sapisochin, MD
  • Treatment for post-transplant lymphoproliferative disorders (PTLD) - Dok Hyun Yoon, MD
  • Q&A
  • Presidential address - Claus Niemann, MD
Presenters
1607517608-1adb89ac7322f96e
Gonzalo Crespo, MD
Moderator
Hospital Clinic de Barcelona, Barcelona, Spain
1607517727-0e01369fbd481bbc
Mark Ghobrial, MD, PhD, FRCS
Moderator
Houston Methodist Hospital, Houston, USA
1607517805-84083cb3338b84fc
Kymberly Watt, MD
Speaker
Mayo Clinic, Rochester, USA
1607517899-398678c8707319fb
José Ignacio Herrero, MD
Speaker
University Clinic of Navarra, Pamplona, Spain
1607517994-70f4220b65c2509a
Gonzalo Sapisochin, MD
Speaker
UHN - Toronto General Hospital, Toronto, Canada
1607518177-a505f8338c344910
Dok Hyun Yoon, MD
Speaker
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
1599565458-bc788b6fd54cb57f
Claus Niemann, MD
Speaker
UCSF, San Francisco, USA